EGFR and cancer: Cinobufagin and cinobufotalin, having same acetylation and different hydroxy, exhibit better selectivity and higher efficiency against cancer cells with EGFR expression and PTEN deletion than resibufogenin (Figure 1D), implying the acetyl group increases the inhibitory effect and 1-hydroxy is not critical.